| Metformin effects on the heart and the cardiovascular system: A review of experimental and clinical data L Nesti, A Natali Nutrition, Metabolism and Cardiovascular Diseases 27 (8), 657-669, 2017 | 221 | 2017 |
| Impact of epicardial adipose tissue on cardiovascular haemodynamics, metabolic profile, and prognosis in heart failure NR Pugliese, F Paneni, M Mazzola, N De Biase, L Del Punta, L Gargani, ... European journal of heart failure 23 (11), 1858-1871, 2021 | 111 | 2021 |
| Type 2 diabetes and reduced exercise tolerance: a review of the literature through an integrated physiology approach L Nesti, NR Pugliese, P Sciuto, A Natali Cardiovascular Diabetology 19 (1), 134, 2020 | 91 | 2020 |
| Rethinking pioglitazone as a cardioprotective agent: a new perspective on an overlooked drug L Nesti, D Tricò, A Mengozzi, A Natali Cardiovascular Diabetology 20 (1), 109, 2021 | 79 | 2021 |
| Impact of empagliflozin on subclinical left ventricular dysfunctions and on the mechanisms involved in myocardial disease progression in type 2 diabetes: rationale and design … A Natali, L Nesti, I Fabiani, E Calogero, V Di Bello Cardiovascular diabetology 16, 1-12, 2017 | 57 | 2017 |
| Circulating palmitoleic acid is an independent determinant of insulin sensitivity, beta cell function and glucose tolerance in non-diabetic individuals: a longitudinal analysis D Tricò, A Mengozzi, L Nesti, M Hatunic, R Gabriel Sanchez, T Konrad, ... Diabetologia 63, 206-218, 2020 | 50 | 2020 |
| Impact of nutrient type and sequence on glucose tolerance: physiological insights and therapeutic implications L Nesti, A Mengozzi, D Tricò Frontiers in Endocrinology 10, 144, 2019 | 45 | 2019 |
| Autoimmune limbic encephalitis related to SARS-CoV-2 infection: case-report and review of the literature C Pizzanelli, C Milano, S Canovetti, E Tagliaferri, F Turco, S Verdenelli, ... Brain, behavior, & immunity-health 12, 100210, 2021 | 41 | 2021 |
| Effects of GLP-1 receptor agonists and SGLT-2 inhibitors on cardiac structure and function: a narrative review of clinical evidence A Natali, L Nesti, D Tricò, E Ferrannini Cardiovascular Diabetology 20 (1), 196, 2021 | 40 | 2021 |
| Persistent congestion, renal dysfunction and inflammatory cytokines in acute heart failure: a prognosis study NR Pugliese, I Fabiani, L Conte, L Nesti, S Masi, A Natali, PC Colombo, ... Journal of Cardiovascular Medicine 21 (7), 494-502, 2020 | 38 | 2020 |
| Metformin is the key factor in elevated plasma growth differentiation factor‐15 levels in type 2 diabetes: A nested, case–control study A Natali, L Nesti, E Venturi, AC Shore, F Khan, K Gooding, PE Gates, ... Diabetes, Obesity and Metabolism 21 (2), 412-416, 2019 | 35 | 2019 |
| The insulinotropic effect of a high-protein nutrient preload is mediated by the increase of plasma amino acids in type 2 diabetes D Tricò, S Frascerra, S Baldi, A Mengozzi, L Nesti, A Mari, A Natali European journal of nutrition 58, 2253-2261, 2019 | 34 | 2019 |
| Characterization of hemodynamic and metabolic abnormalities in the heart failure spectrum: the role of combined cardiopulmonary and exercise echocardiography stress test. NR Pugliese, A Balletti, F Filidei, A Pieroni, G D'Angelo, S Armenia, ... Minerva cardiology and angiology 70 (3), 370-384, 2021 | 31 | 2021 |
| Mechanisms of reduced peak oxygen consumption in subjects with uncomplicated type 2 diabetes L Nesti, NR Pugliese, P Sciuto, N De Biase, M Mazzola, I Fabiani, D Trico, ... Cardiovascular Diabetology 20 (1), 124, 2021 | 29 | 2021 |
| Epicardial adipose tissue thickness is associated with reduced peak oxygen consumption and systolic reserve in patients with type 2 diabetes and normal heart function L Nesti, NR Pugliese, M Chiriacò, D Trico, S Baldi, A Natali Diabetes, Obesity and Metabolism 25 (1), 177-188, 2023 | 24 | 2023 |
| Glomerular hyperfiltration predicts kidney function decline and mortality in type 1 and type 2 diabetes: a 21-year longitudinal study D Moriconi, L Sacchetta, M Chiriacò, L Nesti, G Forotti, A Natali, A Solini, ... Diabetes Care 46 (4), 845-853, 2023 | 18 | 2023 |
| Effect of empagliflozin on left ventricular contractility and peak oxygen uptake in subjects with type 2 diabetes without heart disease: results of the EMPA-HEART trial L Nesti, NR Pugliese, P Sciuto, D Trico, A Dardano, S Baldi, S Pinnola, ... Cardiovascular Diabetology 21 (1), 181, 2022 | 17 | 2022 |
| Prognostic value of 24‐hour ambulatory blood pressure patterns in diabetes: A 21‐year longitudinal study M Chiriacò, L Sacchetta, G Forotti, S Leonetti, L Nesti, S Taddei, A Natali, ... Diabetes, Obesity and Metabolism 24 (11), 2127-2137, 2022 | 16 | 2022 |
| Synergistic effect of chronic kidney disease, neuropathy, and retinopathy on all-cause mortality in type 1 and type 2 diabetes: a 21-year longitudinal study L Sacchetta, M Chiriacò, L Nesti, S Leonetti, G Forotti, A Natali, A Solini, ... Cardiovascular Diabetology 21 (1), 233, 2022 | 15 | 2022 |
| Statins, LDL Cholesterol control, cardiovascular disease prevention, and atherosclerosis progression: a clinical perspective L Nesti, A Mengozzi, A Natali American Journal of Cardiovascular Drugs 20, 405-412, 2020 | 15 | 2020 |
Andrea NataliUniversity of Pisa在 med.unipi.it 的电子邮件经过验证
